N-Terminal Pro-B-Type Natriuretic Peptide-Guided, Intensive Patient Management in Addition to Multidisciplinary Care in Chronic Heart Failure A 3-Arm, Prospective, Randomized Pilot Study

被引:181
作者
Berger, Rudolf [1 ]
Moertl, Deddo [1 ]
Peter, Sieglinde [1 ]
Ahmadi, Roozbeh [1 ]
Huelsmann, Martin [1 ]
Yamuti, Susan [2 ]
Wagner, Brunhilde [3 ]
Pacher, Richard [1 ]
机构
[1] Med Univ Vienna, Dept Cardiol, A-1090 Vienna, Austria
[2] Hosp Hietzing, Dept Cardiol, Vienna, Austria
[3] Hosp Sozialmed, Zentrum Ost, Dept Cardiol, Vienna, Austria
关键词
chronic heart failure; multidisciplinary care; nurse; natriuretic peptide; HIGH-RISK; ELDERLY-PATIENTS; ADMISSION; THERAPY; OUTCOMES; CARVEDILOL; SURVIVAL; MODERATE; PROGRAM; DEATH;
D O I
10.1016/j.jacc.2009.08.078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study was designed to investigate whether the addition of N-terminal pro-B-type natriuretic peptide-guided, intensive patient management (BM) to multidisciplinary care (MC) improves outcome in patients following hospitalization due to heart failure (HF). Background Patients hospitalized due to HF experience frequent rehospitalizations and high mortality. Methods Patients hospitalized due to HF were randomized to BM, MC, or usual care (UC). Multidisciplinary care included 2 consultations from an HF specialist who provided therapeutic recommendations and home care by a specialized HF nurse. In addition, BM included intensified up-titration of medication by HF specialists in high-risk patients. NT-proBNP was used to define the level of risk and to monitor wall stress. This monitoring allowed for anticipation of cardiac decompensation and adjustment of medication in advance. Results A total of 278 patients were randomized in 8 Viennese hospitals. After 12 months, the BM group had the highest proportion of antineurohormonal triple-therapy (difference among all groups). Accordingly, BM reduced days of HF hospitalization (488 days) compared with the hospitalization for the MC (1,254 days) and UC (1,588 days) groups (p < 0.0001; significant differences among all groups). Using Kaplan-Meier analysis, the first HF rehospitalization (28%) was lower in the BM versus MC groups (40%; p = 0.06) and the MC versus UC groups (61%; p = 0.01). Moreover, the combined end point of death or HF rehospitalization was lower in the BM (37%) than in the MC group (50%; p < 0.05) and in the MC than in the UC group (65%; p = 0.04). Death rate was similar between the BM (22%) and MC groups (22%), but was lower compared with the UC group (39%; vs. BM: p < 0.02; vs. MC: p < 0.02). Conclusions Compared with MC alone, additional BM improves clinical outcome in patients after HF hospitalization. (BNP Guided Care in Addition to Multidisciplinary Care; NCT00355017) (J Am Coll Cardiol 2010;55:645-53) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:645 / 653
页数:9
相关论文
共 27 条
[1]   B-type natriuretic peptide predicts sudden death in patients with chronic heart failure [J].
Berger, R ;
Huelsman, M ;
Strecker, K ;
Bojic, A ;
Moser, P ;
Stanek, B ;
Pacher, R .
CIRCULATION, 2002, 105 (20) :2392-2397
[2]   How much responsibility should heart failure nurses take? [J].
Blue, L ;
McMurray, J .
EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (03) :351-361
[3]   Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure [J].
Bristow, MR ;
Gilbert, EM ;
Abraham, WT ;
Adams, KF ;
Fowler, MB ;
Hershberger, RE ;
Kubo, SH ;
Narahara, KA ;
Ingersoll, H ;
Krueger, S ;
Young, S ;
Shusterman, N .
CIRCULATION, 1996, 94 (11) :2807-2816
[4]   A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study [J].
Cheng, V ;
Kazanagra, R ;
Garcia, A ;
Lenert, L ;
Krishnaswamy, P ;
Gardetto, N ;
Clopton, P ;
Maisel, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :386-391
[5]   Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death - The trans-European network-home-care management system (TEN-HMS) study [J].
Cleland, JGF ;
Louis, AA ;
Rigby, AS ;
Janssens, U ;
Balk, AHMM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) :1654-1664
[6]   Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure [J].
Davis, ME ;
Richards, AM ;
Nicholls, G ;
Yandle, TG ;
Frampton, CM ;
Troughton, RW .
CIRCULATION, 2006, 113 (07) :977-985
[7]   Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure [J].
Ekman, I ;
Andersson, B ;
Ehnfors, M ;
Matejka, G ;
Persson, B ;
Fagerberg, B .
EUROPEAN HEART JOURNAL, 1998, 19 (08) :1254-1260
[8]   Association between performance measures and clinical outcomes for patients hospitalized with heart failure [J].
Fonarow, Gregg C. ;
Abraham, William T. ;
Albert, Nancy M. ;
Stough, Wendy Gattis ;
Gheorghiade, Mihai ;
Greenberg, Barry H. ;
O'Connor, Christopher M. ;
Pieper, Karen ;
Sun, Jie Lena ;
Yancy, Clyde ;
Young, James B. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (01) :61-70
[9]  
Jaarsma T, 2004, Eur J Cardiovasc Nurs, V3, P271, DOI 10.1016/j.ejcnurse.2004.10.002
[10]   Effect of moderate or intensive disease management program on outcome in patients with heart failure [J].
Jaarsma, Tiny ;
van der Wal, Martje H. L. ;
Lesman-Leegte, Ivonne ;
Luttik, Marie-Louise ;
Hogenhuis, Jochem ;
Veeger, Nic J. ;
Sanderman, Robbert ;
Hoes, Arno W. ;
van Gilst, Wiek H. ;
Lok, Dirk J. A. ;
Dunselman, Peter H. J. M. ;
Tijssen, Jan G. P. ;
Hillege, Hans L. ;
Van Veldhuisen, Dirk J. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (03) :316-324